☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
advanced solid tumors
BridgeBio Enters into Clinical Collaboration with BMS to Evaluate BBP-398 + Opdivo for Advanced Solid Tumors with KRAS Mutations
July 28, 2021
Hutchmed Initiates P-I Trial of HMPL 295 for the Treatment of Advanced Solid Tumors in China
July 6, 2021
Bayer Seeks Approval of Larotrectinib for Advanced Solid Tumors in China
May 25, 2021
Exelixis Reports the US FDA's Acceptance of IND for XB002 in Patients with Advanced Solid Tumors
April 6, 2021
Strata Oncology Collaborates with Mirati Therapeutics to Broaden Enrollment in Clinical Trial of MRTX849 for Patients with Advance...
August 13, 2020
BioInvent Collaborates with MSD to Evaluate BI-1206 in Combination with Keytruda (pembrolizumab) for Advanced Solid Tumors
December 18, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.